1-4 of 4
Michel Roberge
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Caspase-3–Dependent Mitotic Checkpoint Inactivation by the Small-Molecule Inducers of Mitotic Slippage SU6656 and Geraldol

Jenna L. Riffell, Reiner U. Jänicke, Michel Roberge
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (5): 839–849.
DOI: https://doi.org/10.1158/1535-7163.MCT-10-0909
Published: 08 May 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage

Christopher M. Sturgeon, Zachary A. Knight, Kevan M. Shokat, Michel Roberge
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 885–892.
DOI: https://doi.org/10.1158/1535-7163.MCT-05-0358
Published: 28 April 2006
View article
PDF
Journal Articles

Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions

Lianne M. McHardy, Kaoru Warabi, Raymond J. Andersen, Calvin D. Roskelley, Michel Roberge
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (5): 772–778.
DOI: https://doi.org/10.1158/1535-7163.MCT-04-0310
Published: 16 May 2005
View article
PDF
Journal Articles

Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide

Xiuxian Jiang, Baoguang Zhao, Robert Britton, Lynette Y. Lim, Dan Leong, Jasbinder S. Sanghera, Bin-Bing S. Zhou, Edward Piers, Raymond J. Andersen, Michel Roberge
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (10): 1221–1227.
DOI: https://doi.org/10.1158/1535-7163.1221.3.10
Published: 14 October 2004
View article
PDF